The addition of sorafenib to transarterial chemoembolization improved PFS among patients with unresectable hepatocellular carcinoma, according to results of a randomized phase 2 trial presented at ...

BOSTON — Transarterial chemoembolization with vitamin K dosing improved anticancer outcomes of objective response and progression-free survival in patients with hepatocellular carcinoma ...

Nature Reviews Gastroenterology & Hepatology - Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?

Efficacy and safety of anlotinib combined with transarterial chemoembolization versus transarterial chemoembolization alone in patients with unresectable hepatocellular carcinoma: A retrospective ...

To determine survival outcomes and predictors of mortality among patients who received transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at MCM Hospital in Addis Ababa, ...

Materials & methods: Sixty two Chinese patients (median age 52 years) with unresectable hepatocellular carcinoma had transarterial chemoembolization (TACE) performed with an emulsion of Lipiodol ...

The latest published report namely Global Transarterial Chemoembolization (TACE) Market Size, Share, Growth, Industry Trends and Forecast to 2028 added by Data Bridge Market Research contains point by ...

Hansen Medical, Inc. -- An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology Meeting , found the use of the Magellan™ Robotic System in transarterial ...

Researchers from China report that in patients with peptic ulcer bleeding in whom endoscopy failed to control the bleeding, transarterial embolization is a safe procedure which reduces the need ...